Moloney murine leukaemia virus (MMuLV) is a member of the retrovirus family. Its cloned reverse transcriptase (RT), similarly to HIV type 1 reverse transcriptase (HIV1 RT), exhibits DN Apolymerast and ribonuclease H (RNlase H) activities capable of converting the singlestranded retroviral RNA genome into doublestranded DNA. The latter is then integrated into the host chromosome during viral infection. MMuLV RT is, therefore, an attractive enzyme to help understand mutations in HIV I KI and its use in inhibition studies can help facilitate new drug designs. In this study, conjugates consisting of .Vtrityl derivatives of />fluoro, pnitro and piodoDLphenylalanine were coupled to 8(6aminohexyl) aminoadenosine3'3'cyclic monophosphate and examined for their effect on DNA synthesis by MMuLV RT. Synthesis was studied in a system containing poly (rA}.o!igo d(pT) l5 as a templateprimer with ['HI dTTP. The iododerivative, ,Vtrityl/>iodoDLpheny la lanine8(6 aminohcxyl) aminoadcnosine3',5'cyclic monophosphate was found to be a very active inhibitor of the RT enzyme (1C W = 1 uM), while the pnitro (IC M = 45 uM) and ;>fluoro (IC*, = 65 uM) were weak inhibitors. Further work will be aimed at determining the mode of binding of the AMritylated conjugates and also of various substituted amino acids and short peptides to MMuLV RT to elucidate the mechanisms of inhibition.
INTRODUCTION
In a recent article' we described the synthesis of a number of A r acylated derivatives of 8(6aminohexyl) aminoadenosine5'monophosphate. These various acylated derivatives, as well as the free \trityl substituted DLphenylalanyl amino acids, were tested for their effect on tlie DNA polymerase activity of the Moloney murine leukaemia virus reverse transcriptase (MMuLV RT). A number of these compounds inhibited the enzyme with IC W values (the concentration at which 50% inhibition of activity occurs) of 60 uM 100 uM. If one particular compound, ( Vtrityl/»ifluoroDLphenylalanine, was attached to the nucleotide 8<6aminohexyl) aminoadenosine5'monophosphate ( Figure 1 ), the inhibitor)' activity increased, giving an IC W value of 5 uM.
MMuLV RT is a cloned enzyme expressed in Esclwrkhia toh as a single polypeptide (71 kDa> : and, similarly to HIV type 1 revcrsetranscriptase(HlVlRT),exhibitsboth DNApolymerase and ribonuclease H (RNase H) activities'; the common properties of MMuLV RT and HIV 1RT suggest that the two enzymes are able to carry out identical biological functions as far as the mechanism of DNA synthesis is concerned. Furthermore, the amino acid sequences of several drugresistant mutations of HIV1 RT have revealed similarities to the native sequences found in the MMul.V RT catalytic fragment,* which makes MMuLV RT an attractive enzyme to help understand mutations in HIV1 RT and its use in inhibition studies can help facilitate new drug designs.
In our previous paper, 1 we made the assumption that the nucleotide component (5'AMP) of Un conjugate A'tritylmfluoroDLphenyIalanine8(6aminohexyl) aminoadenosine5'monophosphate could possibly bind to the polymerase site (area) of MMuLV RT, while the A'tritylmfluoroDL phenylalanine grouping was likely to interact with a hydrophobic pocket or area situated 10 A 15 A away. The binding of the conjugate therefore resembled the interaction of certain chimeras with HIV1 RT. We now realise that the suggested binding of (he A'-lrityl conjugates mentioned above may have been entirely wrong and that other areas or sites on the RT enzyme may possibly have been involved (see Discussion).
It was therefore of particular interest to see if replacement of the nucleotide adenosine-5'-phosphate component of A'-trityl-/r-substituted-DL-phenylalanine-8-(6-aminohexyl) amino-adenosine-5'-monophosphate by adenosine-3',5'-cyclic monophosphate would result in inhibitory derivatives against the reverse transcriptase. This paper outlines the synthesis of three compounds containing8-(6-aminohexyl(amino-adenosine-3',5'-cyc!ic monophosphate that are linked to different A-trityl-/>substitutcd-DL-pheny(alanines (p-fluoro, p-nitro and p-iodo; Figure 2 ) and their effects on the DNA polymerase activity of M-MuLV RT.
It would have been logical to use m-derivatives (wfluoro, m-nitro and m-iodo) of Dl.-phenylalanine in these new conjugates with 3',5'-cyclic-AMP. Our reason for using the jV-tritylatedp-substituted DL-phenylalanine derivatives was that we had adequate amounts of crystalline A'-hydroxysuccinim (deactivated esters of these A'-tritylated-/>-substituted amino acids, while the m-substituted derivatives were not available.
MATERIALS AND METHODS
Poly (rA) and 8-(6-aminohexyl) amino-adcnosinc-3',5'-cyclic monophosphate were supplied by Sigma (St Louis, United States of America). Oligo d(pT)" and M-MuLV RT were supplied by Roche (Mannheim, Germany). The PH] dTTP (65.5 Ci/mmol) used as the tetrasodium salt was obtained from American Radiolabeled Chemicals (St Louis, USA). All other chemical reagents were of analytical grade.
We synthesised three new conjugates, as detailed below. The A-tritylated amino acids used were .V-trityl-/>-fluoro-DLpheny(alanine, A'-rrityl-p-nitro-DI.-phenylalanine and A'-trityl-/•-iodo-DL-phenylalanine. The .V-tritylated phenylalanines were activated as their A'-hydroxysuccinimide derivatives, which were then coupled to 8-(6-aminohexyl) amino-adcnosine-3',5'<yclic monophosphate ( Figure 2 ). A'-trityl'/t-fluoro-DL-phenylalanine, A'-trityl-/>-nitro-DL-phenylalaninc and A'-trityl-p-iodo-DLphenylalanine were prepared as described previously by Nel and AriattT, using the method of Zervas and Theodoropoulos". The A f -hydroxysuccinimide derivatives of the above compounds were prepared according to the procedure of Nel and Ariatti'.
Assay for RNA-dependent DNA polymerase activity of M-MuLV RT The incubation system contained 50 mM Tris-HCI (pH 8.3), 20 mM KCI, 10 mM dithiothreitol, 5 mM MgCL reverse transcriptase (10 units), poly rA (1.0 ug), d(pT)" primer (0.1 Mg),rH|dTTP(1.25(.Ci)anddTTP(05Mg).inafinal volume of 20 ul-Reactions were carried out at 37 °C. Aliquots (4 uL) were removed at regular 1 min intervals after commencing the run and mixed into 20 |iL 0.1 M EDTA (pH 7.0). From these solutions, aliquots (7 uL), were removed and streaked onto discs of DE-81 paper, dried at 37 e C and then placed in 0.5 M sodium phosphate (pll 6.8) for 5 min. This procedure was repeated with fresh 0.5 M phosphate. Discs were dried at 60 "C and radioactivity was assessed bv liquid scintillation. Test compounds were dissolved in ethanol or 0.05 M Tris-HCI (pH 7.6). The final concentration of ethanol in test runs and controls was 10% (vA-). .Y-trityl-/»-iodo-DL-phenylalanine-8-(6-aminohexyl) amino-adenosine-3',5'-cyclic monophosphate This compound was also similarly prepared as described above for the />*fluoro derivative. The synthesis used 8-(6-aminohexyl) amino-adenosinc-3',5'-cyclic monophosphate (4.7 mg, 0.01 mmol) and the A'-hydroxysuccinimide ester of A'-triryl-p-iodo-DL-phenylalanine (6.4 mg, 0.01 mmol). Following isolation by TLC, the pure derivative was dissolved in ethanol and gave a single spot on TLC (silica gel 6OF3J, with an R, of 0.78 using ethanoLH.O (5:1, v/v). With ethanol as a solvent, the UV had a X -o of273nm and a 273-244 ratio of 2.13. When run in negative mode, the mass spectrum m/z ratios were 243.1 (trityl), 444.2, 717.1,734.6 and 960.3 (molecular mass = 960.5). In positive mode, the mass spectrum results showed mlz ratios of 442.1,510.1,957.1 and 958.1 (molecular mass -960.5).
RESULTS AND DISCUSSION
Previous work from our laboratory' described the effects of various iV-trityl amino acids, as well as the conjugate compound A'-trityl-m-fluoro-DL-phenvlalanine-8-(6-aminohexyl) aminoadenosine-5'-monophosphate, on the activity of cnzyme-MuLV RT (Figure 1 ). The N-tritylated amino acids all inhibited the reverse transcriptase with IC W values varying between 95 uM and 65 uM. When .V-irityl-m-fluoro-OL-phcnylalanine was chemically coupled to the 6-amino-side chain of 8-(6-aminohexyl> amino-adenosine-5'-monophosphate, however, the resulting conjugate showed a dramatic increase in inhibitory activity, with an IC^, value of 5 uM; we have previously discussed possible reasons for this and also suggested how the conjugate might bind to the reverse transcriptase enzyme. 1 In this study, we wished to examine whether the replacement of the adcnosinc-5'-monophosphate component of A , -trityl-^fluoro-DL-phenylalanine-8-(6-aminohexyl) aminoadenosine-5'-monophosphate with 8-(6-aminohexyl> aminoadenosine-3',5'-cyclic monophosphate would result in a conjugate with an inhibitory effect on the reverse transcriptase enzyme. We therefore synthesised three new conjugates: A'-trityl-/>-fluoro-DL-phenylalanine, A'-trityl-/j-nitro-DL-phenylalanine and A'-trityl-/>-iodo-DL-phenylalanirte.
Assays for reverse transcriptase activity (reported as IC W values) were carried out using poly (rA)-d(pT)^ as the templateprimer and measuring incorporation of |'H|dTTP into newly synthesised DNA (poly dT)' ( Table 1 ). The/>-iodo derivative was clearly a good inhibitor (1C W = 1 uM), while the />-nitro (IC M -45 uM) and p-fluoro (IC W ■ 65 JIM) derivatives were weak inhibitors. The molecular/ kinetic reasons for these differences are notapparentat present. It is worth noting that the 8-(6-aminohexyl) amino-adenosine-3'S-cyclic monophosphate that was run as a control resulted in a weak inhibition of the reverse transcriptase enzyme (IC W = 800 uM).
The strongly inhibitory activity of the /»-iodo derivative is interesting; the iodine atom has a large radius (covalent radius = 133 A) and is lipophilic, whilst fluorine and bromine have covalent radii of 0.72 A and 1.14 A, respectively. The large covalent radius of the iodine atom may have had some bearing on the activity of the nucleotide conjugate.
Cushmanandcolleagues"synthesisedanumberofHlV-l reverse transcriptase inhibitors, of which one of the most active was 3'3"-dibromo-4',4"-dimethoxy-5'^"-bis(methoxycarbonyl)-l,ldiphenyl-l-heptene. They reported that replacement of the two bromine atoms in the above compound with two chlorine atoms resulted in a compound with decreased H1V-1 RT inhibitory activity.
In this study, the compounds synthesised and evaluated as inhibitors of the M-MuLV RT were originally visualised as chimeras. Several other researchers*' 10 "' 11 originally suggested the idea of cross-linking a non-nucleoside compound, specifically a non-nucleoside reverse transcriptase inhibitor (NNRTI), to substrates (i.e. the formation of a chimera). As reported in our previous paper, 1 the design features of the nucleotide-A'-trityl-m-fluoro-DL-phenylalanine appear to be consistent with these ideas. The concept of chimera structures binding to M-MuLV RT was prominent in our thinking when we began to carry out the work reported in the present paper. We now believe thai the evidence for a chimera-type inhibitor and the mechanism we proposed, that is, of conjugates binding to M-MuLV RT, is incorrect, for the reasons outlined below.
TABLE 1
The effect ol different \ Intyl/substituted DLphe»ylaUruie846e<riinol>exyl)
•™*>«l«no*ne3\5 cycle rwjnophoepnala* on DNA syntheM by Moloney murine leukaemia vwus reverse tranacnpUee Binding of A'-trityl-p-fluoro-DL-phenylalanine-8-(6-aminohexyl) amino-adenosine-3',5'-cyclic monophosphate and the p-nitro and p-iodo substituted DL-phenylalanine conjugates to M-MuLV RT 11IV-1 RT is possibly the most extensively studied enzyme and a multitude of studies on its crystal structure have been reported.
011
Although there are distinct structural differences between the monomeric M-MuLV RT and the heterodimeric HIV-1 RT, it is important to keep in mind that the respective polymerase domains of M-MuLV RT and HIV-1 RT are approximately 85% structurally similar."" This similarity allows the use of M-MuLV-RT as a tool in order better to understand the reverse transcription process and the design of novel inhibitors for HIV-1 RT. We do not know how the M-MuLV RT binds NNRTIs, whether there is a hydrophobic pocket present, or whether the inhibitor can induce allosteric changes in the enzyme structure. It is also unlikely that the nucleotide (5'-AMP or 3',5'-cyclic-AMP) component of the conjugate is binding near, or at, the polymerase site, as these are not deoxyribose nucleoside triphosphates but ribosc-containing nucleotides. Also, inhibition, when it occurs, should be non-competitive. When using A-tritylm-fluoro-DL-phenylalanine-8-<6-aminohexyl) amino-adenosine-5'-monophosphate in our original paper, 1 we performed competition experiments using varying concentrations of poly rA, d(pT) ls at fixed concentrations of jV-trityl-m-fluoro-DLphenylalanine-nucleotide, which showed the compound acted as a non-competitive inhibitor (results not published).
It is thus unlikely that the DL-phenyl conjugates would fit into both the polymerase binding area and the nearby allosteric pocket site. Based on our results, we propose that other areas of the M-MuLV RT enzyme are being used for the attachment and functioning of the (V-tritylated conjugates.
A number of research groups have reported on the synthesis and biological evaluation of dimers, some of which behave as true chimeras, The TSAO-T molecule does not bind in the hydrophobic pocket of the HIV-1 RT, but rather interacts with certain amino acids at the interface of the p5l and p66 subunits. Velazquez et al." believe that the (AZT)-[TSAO-T) dimer works only through the NNRTI portion of the molecule and not through the AZT (ddN) segment. It should be noted that TSAO is also a ribose derivative. The |AZT|-(CII : ) n -lTSAO-T) structure is shown in Figure 3 .
A recent paper by Tomassi et al.* deals with the synthesis of new TSAO-T derivatives, particularly TSAO-BocT. The introduction of a Boc grouping to the \-3 position of the thymidine ring creates a good inhibitor of HIV-1 RT activity. Besides details of the synthesis and biological evaluation of this inhibitor, they report on computational analysis regarding the binding site of the enzyme.* Our further work will be aimed at determining the mode of binding of the /V-tritylated conjugates and also of various substituted amino acids and short peptides to M-MuLV RT, in order to resolve the abovementioned uncertainties.
